Slingshot Insights | Armo Overview

ARMO Overview

Upcoming Projects (ARMO)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (ARMO)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (ARMO)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (ARMO)

Phase 2 pegilodecakin (PEG-rhuIL-10) in combination with PD-1 antibody (pembrolizumab or nivolumab) in second-line NSCLC
Ticker: ARMO
Occurred on: Jun 02, 2018
Phase 1 pegilodecakin (PEG-rhuIL-10) combination with anti-PD-1 antibodies, and combination with FOLFOX in renal cell carcinoma, pancreatic cancer, and non-small cell lung cancer
Ticker: ARMO
Occurred on: Jan 11, 2018

Strategic Initiatives (ARMO)

Don’t see a strategic initiative related to the company you care about? Create your own!